Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
Нехирургические методы лечения острой, подострой и хронической боли в пояснице: клиническая практика — руководство Американского колледжа врачей
2017-02-13
SCID: 54.1/994269s6
Discuss with AI
acupuncturecognitive behavioral therapylow back painnoninvasive treatmentnonsteroidal anti-inflammatory drugs (NSAIDs)
Figures from the paper
Abstract (AI)
Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on noninvasive treatment of low back pain. Methods: Using the ACP grading system, the committee based these recommendations on a systematic review of randomized, controlled trials and systematic reviews published through April 2015 on noninvasive pharmacologic and nonpharmacologic treatments for low back pain. Updated searches were performed through November 2016. Clinical outcomes evaluated included reduction or elimination of low back pain, improvement in back-specific and overall function, improvement in health-related quality of life, reduction in work disability and return to work, global improvement, number of back pain episodes or time between episodes, patient satisfaction, and adverse effects. Target Audience and Patient Population: The target audience for this guideline includes all clinicians, and the target patient population includes adults with acute, subacute, or chronic low back pain. Recommendation 1: Given that most patients with acute or subacute low back pain improve over time regardless of treatment, clinicians and patients should select nonpharmacologic treatment with superficial heat (moderate-quality evidence), massage, acupuncture, or spinal manipulation (low-quality evidence). If pharmacologic treatment is desired, clinicians and patients should select nonsteroidal anti-inflammatory drugs or skeletal muscle relaxants (moderate-quality evidence). (Grade: strong recommendation). Recommendation 2: For patients with chronic low back pain, clinicians and patients should initially select nonpharmacologic treatment with exercise, multidisciplinary rehabilitation, acupuncture, mindfulness-based stress reduction (moderate-quality evidence), tai chi, yoga, motor control exercise, progressive relaxation, electromyography biofeedback, low-level laser therapy, operant therapy, cognitive behavioral therapy, or spinal manipulation (low-quality evidence). (Grade: strong recommendation). Recommendation 3: In patients with chronic low back pain who have had an inadequate response to nonpharmacologic therapy, clinicians and patients should consider pharmacologic treatment with nonsteroidal anti-inflammatory drugs as first-line therapy, or tramadol or duloxetine as second-line therapy. Clinicians should only consider opioids as an option in patients who have failed the aforementioned treatments and only if the potential benefits outweigh the risks for individual patients and after a discussion of known risks and realistic benefits with patients. (Grade: weak recommendation, moderate-quality evidence).
Key Findings
1
For acute or subacute low back pain, select nonpharmacologic treatments such as superficial heat (moderate-quality evidence), massage, acupuncture, or spinal manipulation (low-quality evidence).
2
For chronic low back pain, initially select nonpharmacologic treatments including exercise, multidisciplinary rehabilitation, acupuncture, mindfulness-based stress reduction (moderate-quality evidence), tai chi, yoga, motor control exercise, progressive relaxation, EMG biofeedback, low-level laser therapy, operant therapy, cognitive behavioral therapy, or spinal manipulation (low-quality evidence).
3
If chronic low back pain does not respond to nonpharmacologic therapy, consider NSAIDs as first-line pharmacologic therapy, with tramadol or duloxetine as second-line options (moderate-quality evidence).
4
If pharmacologic treatment is desired for acute or subacute low back pain, choose NSAIDs or skeletal muscle relaxants (moderate-quality evidence).
5
Most patients with acute or subacute low back pain improve over time regardless of treatment, informing preference for nonpharmacologic initial therapies (rationale for recommendations).
6
Opioids should be considered only after failure of the above treatments and when benefits outweigh risks, following discussion of known risks and realistic benefits (weak recommendation).
Research Object
Noninvasive treatments for acute, subacute, and chronic low back pain in adults
Research Subject
Clinical effectiveness and recommendations (benefits, harms, and comparative guidance) of noninvasive pharmacologic and nonpharmacologic interventions for reducing low back pain, improving function and quality of life, and impacting work disability
Publication Details
Publication Date
2017-02-13
Journal
Publisher
ISSN
Cited by
3484
Access Type
Author Information
Download PDF
Subscribe to digest